Kao Y C, Korzekwa K R, Laughton C A, Chen S
Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
Eur J Biochem. 2001 Jan;268(2):243-51. doi: 10.1046/j.1432-1033.2001.01886.x.
Aromatase (CYP19) catalyzes three consecutive hydroxylation reactions converting C19 androgens to aromatic C18 estrogenic steroids. In this study, five human aromatase mutants (E302D, S478A, S478T, H480K, and H480Q) were prepared using a mammalian cell expression system. These mutants were evaluated by enzyme kinetic analysis, inhibitory profile studies, and reaction intermediate measurements. Three steroidal inhibitors [4-hydroxyandrostenedione (4-OHA), 7alpha-(4'-amino)phenylthio-1,4-androstandiene-3,17-dione (7alpha-APTADD), and bridge (2,19-methyleneoxy) androstene-3,17-dione (MDL 101003)], and four nonsteroidal inhibitors [aminoglutethimide (AG), CGS 20267, ICI D1033, and vorozole (R83842)] were used in the inhibitory profile studies. Our computer model of aromatase suggests that Glu302 is situated in the conserved I-helix region and located near the C-19 position of the steroid substrate. The model was supported by significant changes in kinetic parameters and a sevenfold increase in the Ki value of MDL 101,003 for the mutant E302D. As S478A was found to have kinetic properties similar to the wild-type enzyme and a much higher activity than S478T, Ser478 is thought to be situated in a rather restricted environment. There was a 10-fold increase in the Ki value of 7alpha-APTADD for S478T over that for the wild-type enzyme, suggesting that Ser478 might be near the C-7 position of the substrate. The reaction intermediate analysis revealed that significantly more 19-ol intermediate was generated by both S478A and S478T than the wild-type enzyme. These results would support a hypothesis that Ser478 plays a role in the first and second hydroxylation reactions. A positive charged amino acid is preferred at position 480 as shown by the fact that H480K has a significantly higher activity than H480Q. The Ki value of 4-OHA for H480Q was found to be three times that of the wild-type enzyme. In addition, significantly more 19-ol and 19-al intermediates were detected for both mutants H480K and H480Q than for the wild-type enzyme. Evaluation of the two mutations at His480 allows us to propose that this residue may participate in the aromatization reaction (the third step) by acting as a hydrogen bond donor for the C-3 keto group of the substrate. Furthermore, new products were generated when the enzyme was mutated at Ser478 and His480. Thus, these two residues must play an important role in the catalysis and are likely closer to the substrate binding site than previously predicted.
芳香化酶(CYP19)催化三个连续的羟基化反应,将C19雄激素转化为芳香族C18雌激素类固醇。在本研究中,使用哺乳动物细胞表达系统制备了五个人类芳香化酶突变体(E302D、S478A、S478T、H480K和H480Q)。通过酶动力学分析、抑制谱研究和反应中间体测量对这些突变体进行了评估。在抑制谱研究中使用了三种甾体抑制剂[4-羟基雄烯二酮(4-OHA)、7α-(4'-氨基)苯硫基-1,4-雄甾二烯-3,17-二酮(7α-APTADD)和桥联(2,19-亚甲基氧基)雄烯-3,17-二酮(MDL 101003)]以及四种非甾体抑制剂[氨鲁米特(AG)、CGS 20267、ICI D1033和伏罗唑(R83842)]。我们的芳香化酶计算机模型表明,Glu302位于保守的I螺旋区域,靠近甾体底物的C-19位置。该模型得到了动力学参数的显著变化以及突变体E302D的MDL 101,003的Ki值增加七倍的支持。由于发现S478A具有与野生型酶相似的动力学性质且活性比S478T高得多,因此认为Ser478位于相当受限的环境中。S478T的7α-APTADD的Ki值比野生型酶增加了10倍,表明Ser478可能靠近底物的C-7位置。反应中间体分析表明,S478A和S478T产生的19-醇中间体均比野生型酶多得多。这些结果支持了Ser478在第一次和第二次羟基化反应中起作用的假设。如H480K比H480Q具有显著更高的活性这一事实所示,480位优选带正电荷的氨基酸。发现H480Q的4-OHA的Ki值是野生型酶的三倍。此外,突变体H480K和H480Q检测到的19-醇和19-醛中间体均比野生型酶多得多。对His480处的两个突变的评估使我们能够提出,该残基可能通过作为底物C-3酮基的氢键供体参与芳香化反应(第三步)。此外,当酶在Ser478和His480处发生突变时会产生新产物。因此,这两个残基必定在催化中起重要作用,并且可能比先前预测的更靠近底物结合位点。